| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.18 | 0.005 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |